Cargando…
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
Although the COVID-19 vaccines are currently recommended for people with myasthenia gravis (MG), there is no data regarding the safety of the vaccines in this population. In order to investigate the real-life safety data of the BNT162b2 COVID-19 vaccine in people with MG, an anonymous survey was dis...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817458/ https://www.ncbi.nlm.nih.gov/pubmed/35227552 http://dx.doi.org/10.1016/j.nmd.2022.01.013 |